Synthesis of novel 1-substituted and 1,9-disubstituted-1,2,3,4-tetrahydro- 9H-carbazole derivatives as potential anticancer agents

Molecules

Volumn 5, Issue 10, 2000, Pages 1101-1112

  Shmeiss, N A M M ^a   Ismail, M M F ^b   Soliman, A M ^c   El Diwani, H I ^c  

^a AL AZHAR UNIVERSITY   (Egypt)

^b Assiut Branch   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Carbazole derivatives; Cytotoxic activity; Thiadiazino derivatives

Indexed keywords

1 (2,3,4,9 TETRAHYDRO 1H CARBAZOL 1 YL)ETHYLIDENE AMINOACETIC ACID; 1 (2,3,4,9 TETRAHYDRO 1H CARBAZOL 1 YL)ETHYLIDENE SEMICARBAZONE; 1 (2,3,4,9 TETRAHYDRO 1H CARBAZOL 1 YL)ETHYLIDENE THIOSEMICARBAZONE; 1 (2,3,4,9 TETRAHYDRO 1H CARBAZOL 1 YL)ETHYLIDENE THIOUREA; 1 (2,3,4,9 TETRAHYDROCARBAZOL 1 YL) 2 PHENYL 1 [(3 METHYL 1 PHENYL)PYRAZOL 5 ON 1 YLIDENE]ETHANE; 1 (5 PYRIDIN 3 YL 1H PYRAZOL 3 YL)2,3,4,9 TETRAHYDRO 1H CARBAZOLE; 1 ACETYL 1,2,3,4 TETRAHYDRO 9H CARBAZOLE; 1' [1 (2,3,4,9 TETRAHYDROCARBAZOL 1 YLIDENE) N (THIAZOLIDIN 4 ONE)ETHANAMINE]; 1,2,3,3A TETRAHYDRO[3,3,1 JK]CARBAZOLE 4,7 DIONE; 1,9 DIPHENYLACETYL 1,2,3,4 TETRAHYDROCARBAZOLE; 2 (2,3,4,9 TETRAHYDROCARBAZOL 1 YL) 1 CYANO 1 (5 HYDRO 4 OXO 1,3 THIAZOL 2 YL) 3 PHENYL 1 PROPENE; 3 METHYL 2,4,5,6 TETRAHYDRO[1,2,6]THIADIAZINO[4,3,2JK]CARBAZOL 2 YL AMINO(THIOXO)METHYLAMINOMETHANONE 1 OXIDE; 3 OXO 3 [3 (1,2,3,4,9 PENTAHYDROCARBAZOL 1 YLIDENE)ETHYL]UREIDOPROPIONIC ACID; 3 PYRIDIN 3 YL 1 (2,3,4,9 TETRAHYDRO 1 CARBAZOL 1 YL)PROP 2 EN 1 ONE; 7 ETHYLAMINO 1,2,3,3A TETRAHYDRO[3,3,1 JK]CARBAZOL 4 ONE; ANTINEOPLASTIC AGENT; CARBAZOLE DERIVATIVE; ETHYLAMINE; UNCLASSIFIED DRUG;

ACYLATION; ADDITION REACTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CYCLIZATION; CYTOTOXICITY; DRUG SYNTHESIS; POLYMERIZATION; SUBSTITUTION REACTION;

EID: 3843087595     PISSN: 14203049     EISSN: None     Source Type: Journal    
DOI: 10.3390/51001101     Document Type: Article

References (14)

1. St. Georgiev, V., New Synthetic Immunomodulating Agents, Trends Pharmacol, Sci, 1988, 9, 446-451.
2. R. L. Hudkins, J. L. Diebold, T. S. Angeles and Jr. E. Knight, J. Med. Chem., 1997, 40, 2994-2996.
3. (a) G. H. Svoboda, Lloydia, 24, 173 (1961);
4. (b) R. L. Nable, C. T. Beer, J. H. Cutts and N. Y. Ann, Acad. Sci., 1958, 76, 3, 882.
5. L. K. Dalton, S. Demerac, C. Elmes, J. W. Loder, J. M. Swan and T. Teitei, Aust. J. Chem., 1967, 20, 2715.
6. W. A. Creasy, "Vinca Alkaloids and Colchicine", in "Handbook of Experimental Pharmacology", A. C. Sartarelli and D. J. Johns, eds., Springer Verlag New York, 1975, 39, 670-674.
7. (a) C. Auclair, Arch. Biophys., 1987, 1, 259.
8. (b) M. Suffness, G. A. Cardell, " The Alkaloids", A. Brassi, ed., Academic Press, New York, 1985, 25, 1.
9. (a) B. Dug, C. Auclair and B. Meunier, Cancer Res., 1986, 46, 3828.
10. (b) G. Meunier, D. de Montauzon, J. Bernadou, G. Grassy, M. Bonnafous, S. Cros, and B. Meunier, Mol. Pharmacol., 1988, 33, 93.
11. L. Ding, C. Gasas, G. Etemad-Moghadam, S. Cros and B. Meunier, New J. Chem., 1990, 14, 421.
12. S. D. Ziman, J. Heterocyclic Chem., 1979, 16, 5, 895-96.
13. I. L. Finar, "Heterocyclic Compounds", Longman Group Ltd., London, 6th ed, 1973, vol. 1, 846.
14. M. M. F. Ismail, Az. J. Pharm. Sci., 1999, 23, 82-99.